Literature DB >> 29530539

Focal immune-related pancreatitis occurring after treatment with programmed cell death 1 inhibitors: a distinct form of autoimmune pancreatitis?

Gabriele Capurso1, Livia Archibugi2, Laura Tessieri3, Maria Chiara Petrone4, Andrea Laghi5, Paolo Giorgio Arcidiacono4.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2018        PMID： 29530539     DOI： 10.1016/j.ejca.2018.02.006

Source DB:  PubMed          Journal:  Eur J Cancer        ISSN： 0959-8049            Impact factor:   9.162


× No keyword cloud information.
  4 in total

Review 1.  Clinical Characteristics of ICI-Related Pancreatitis and Cholangitis Including Radiographic and Endoscopic Findings.

Authors:  Ryota Nakano; Hideyuki Shiomi; Aoi Fujiwara; Kohei Yoshihara; Ryota Yoshioka; Shoki Kawata; Shogo Ota; Yukihisa Yuri; Tomoyuki Takashima; Nobuhiro Aizawa; Naoto Ikeda; Takashi Nishimura; Hirayuki Enomoto; Hiroko Iijima
Journal:  Healthcare (Basel)       Date:  2022-04-20

2.  Pembrolizumab-Induced Pancreatic Exocrine Insufficiency Complicated by Severe Hepatic Steatosis.

Authors:  Alex S Hong; Naveed Sarwar; Robert D Goldin; Ameet Dhar; Lucia A Possamai
Journal:  Cureus       Date:  2022-07-05

3.  The diagnosis of immune-related pancreatitis disguised as multifocal lesions on MRI by endoscopic ultrasound-guided fine-needle biopsy: A case report.

Authors:  Wen Shi; Bei Tan; Yuan Li; Liang Zhu; Yunlu Feng; Qingwei Jiang; Jiaming Qian
Journal:  Front Immunol       Date:  2022-09-13       Impact factor: 8.786

4.  Fatal Immune Checkpoint Inhibitor-related Pancreatitis.

Authors:  Masayuki Ueno; Yoshihisa Tsuji; Toshihide Yokoyama; Takashi Koyama; Yosuke Uenishi; Etsuji Ishida; Motowo Mizuno
Journal:  Intern Med       Date:  2021-06-12       Impact factor: 1.271
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.